Text size
Daniel Acker/Bloomberg
Eli Lilly
reported fourth-quarter adjusted earnings of $2.49 a share on sales of $8 billion and shares of the pharmaceutical giant were edging lower in premarket trading Thursday.
Analysts expected Eli Lilly (ticker: LLY) to report fourth-quarter earnings of $2.45 a share on $7.69 billion. A year earlier, Lilly posted a profit of $2.75 on revenue of $7.44 billion.
Covid-19 antibodies revenue was $1.06…
